Kestra Medical Technologies (NASDAQ:KMTS) Trading Down 5.6% - Here's Why

Shares of Kestra Medical Technologies, Ltd. (NASDAQ:KMTS - Get Free Report) traded down 5.6% during trading on Monday . The stock traded as low as $21.01 and last traded at $21.27. 68,622 shares traded hands during mid-day trading, a decline of 64% from the average session volume of 190,155 shares. The stock had previously closed at $22.52.

Wall Street Analyst Weigh In

Several analysts have recently issued reports on KMTS shares. Wolfe Research began coverage on shares of Kestra Medical Technologies in a research report on Monday, March 31st. They set an "outperform" rating and a $29.00 price target on the stock. Wells Fargo & Company initiated coverage on Kestra Medical Technologies in a research report on Monday, March 31st. They set an "overweight" rating and a $28.00 price objective for the company. The Goldman Sachs Group reduced their target price on Kestra Medical Technologies from $24.00 to $23.00 and set a "neutral" rating for the company in a report on Wednesday, April 16th. Piper Sandler initiated coverage on shares of Kestra Medical Technologies in a report on Monday, March 31st. They issued an "overweight" rating and a $27.00 price target on the stock. Finally, Bank of America started coverage on shares of Kestra Medical Technologies in a report on Monday, March 31st. They set a "buy" rating and a $30.00 price target for the company. One investment analyst has rated the stock with a hold rating and five have given a buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of "Moderate Buy" and an average price target of $27.50.

Kestra Medical Technologies Stock Up 0.8%

The company has a 50-day moving average of $23.34.

Kestra Medical Technologies (NASDAQ:KMTS - Get Free Report) last released its earnings results on Monday, April 14th. The company reported ($1.25) EPS for the quarter, missing the consensus estimate of ($0.64) by ($0.61). During the same quarter last year, the business earned ($1.18) EPS.

Institutional Trading of Kestra Medical Technologies

Several large investors have recently made changes to their positions in KMTS. Jane Street Group LLC bought a new stake in Kestra Medical Technologies during the first quarter valued at about $756,000. Woodline Partners LP acquired a new position in shares of Kestra Medical Technologies in the 1st quarter valued at $2,510,000. Yu Fan bought a new position in shares of Kestra Medical Technologies during the 1st quarter worth about $56,880,000. Zimmer Partners LP bought a new position in shares of Kestra Medical Technologies during the 1st quarter worth approximately $374,000. Finally, Millennium Management LLC bought a new stake in Kestra Medical Technologies during the first quarter worth about $11,036,000.

Kestra Medical Technologies Company Profile

We are a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. We have developed and are commercializing our Cardiac Recovery System platform, a comprehensive and advanced system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution.